ATE384800T1 - Multifunktionelle protease-inhibitoren und deren verwendung zur behandlung von krankheiten - Google Patents
Multifunktionelle protease-inhibitoren und deren verwendung zur behandlung von krankheitenInfo
- Publication number
- ATE384800T1 ATE384800T1 AT01988344T AT01988344T ATE384800T1 AT E384800 T1 ATE384800 T1 AT E384800T1 AT 01988344 T AT01988344 T AT 01988344T AT 01988344 T AT01988344 T AT 01988344T AT E384800 T1 ATE384800 T1 AT E384800T1
- Authority
- AT
- Austria
- Prior art keywords
- fusion proteins
- treatment
- protease
- protease inhibitors
- diseases
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/8146—Metalloprotease (E.C. 3.4.24) inhibitors, e.g. tissue inhibitor of metallo proteinase, TIMP
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
- C07K14/8121—Serpins
- C07K14/8125—Alpha-1-antitrypsin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US25669900P | 2000-12-18 | 2000-12-18 | |
US33196601P | 2001-11-20 | 2001-11-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE384800T1 true ATE384800T1 (de) | 2008-02-15 |
Family
ID=26945535
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT01988344T ATE384800T1 (de) | 2000-12-18 | 2001-12-18 | Multifunktionelle protease-inhibitoren und deren verwendung zur behandlung von krankheiten |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1366175B1 (de) |
JP (2) | JP4426179B2 (de) |
AT (1) | ATE384800T1 (de) |
AU (2) | AU2002241661B2 (de) |
CA (1) | CA2430973A1 (de) |
DE (1) | DE60132632T2 (de) |
WO (1) | WO2002050287A2 (de) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2508762A1 (en) * | 2002-12-06 | 2004-06-24 | Arriva Pharmaceuticals, Inc. | Methods and compositions for treatment of otitis media |
WO2004089987A1 (en) * | 2003-04-08 | 2004-10-21 | Genova Ltd. | Secreted polypeptide species associated with cardiovascular disorders |
EP1660661A2 (de) | 2003-08-08 | 2006-05-31 | Arriva Pharmaceuticals, Inc. | Verfahren zur proteinproduktion in hefe |
SE0302559D0 (sv) | 2003-09-25 | 2003-09-25 | Astrazeneca Ab | Method |
AU2005221151A1 (en) | 2004-03-09 | 2005-09-22 | Arriva Pharmaceuticals, Inc. | Treatment of chronic obstructive pulmonary disease by low dose inhalation of protease inhibitor |
JP2007037434A (ja) * | 2005-08-02 | 2007-02-15 | Yamaguchi Univ | 膵β細胞特異的に発現される人工タンパク質、該タンパク質をコードしたレポーター遺伝子及び膵β細胞量の計測方法 |
JP2009532369A (ja) * | 2006-03-30 | 2009-09-10 | リサーチ ファウンデーション オブ シティ ユニバーシティ オブ ニューヨーク | 分泌性白血球プロテアーゼインヒビターによる神経再生の刺激 |
US8802627B2 (en) | 2008-10-09 | 2014-08-12 | Oriental Yeast Co., Ltd. | Fusion protein composed of matrix metalloproteinase-2 inhibitor peptide derived from amyloid-B precursor protein and tissue inhibitor of metalloproteinase-2 |
EP2616487B1 (de) * | 2010-09-14 | 2015-03-25 | F.Hoffmann-La Roche Ag | Serpin-finger-fusionspolypeptid |
AU2012275287B2 (en) | 2011-06-28 | 2017-10-05 | Inhibrx, Inc. | Serpin fusion polypeptides and methods of use thereof |
US10400029B2 (en) | 2011-06-28 | 2019-09-03 | Inhibrx, Lp | Serpin fusion polypeptides and methods of use thereof |
SG10201610913PA (en) | 2011-12-30 | 2017-02-27 | Grifols Sa | Alpha1-proteinase inhibitor for delaying the onset or progression of pulmonary exacerbations |
JP6436401B2 (ja) * | 2013-04-30 | 2018-12-12 | ザ トラスティーズ オブ コロンビア ユニバーシティ イン ザ シティ オブ ニューヨーク | 弾性繊維損傷マーカーの解析 |
US20160235813A1 (en) * | 2013-09-18 | 2016-08-18 | James Cook University | Anti-inflammatory proteins and methods of use |
CN105745223A (zh) | 2013-09-18 | 2016-07-06 | 詹姆斯库克大学 | 修饰的抗炎蛋白及使用方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5900400A (en) * | 1984-12-06 | 1999-05-04 | Amgen Inc. | Serine protease inhibitor analogs |
DE3709255A1 (de) * | 1987-03-20 | 1988-09-29 | Hoechst Ag | Hybridserpine und dafuer kodierende dna |
US5633227A (en) * | 1994-09-12 | 1997-05-27 | Miles, Inc. | Secretory leukocyte protease inhibitor as an inhibitor of tryptase |
EP0981606A2 (de) * | 1997-05-12 | 2000-03-01 | Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno | Verfahren und vektor zur hemmung der zell-migration |
EP1231936A2 (de) * | 1999-10-27 | 2002-08-21 | K-Quay Enterprises, LLC | Verfahren und zusammensetzungen für behandlung von keratokonus mit proteaseinhibitoren |
-
2001
- 2001-12-18 DE DE60132632T patent/DE60132632T2/de not_active Expired - Lifetime
- 2001-12-18 EP EP01988344A patent/EP1366175B1/de not_active Expired - Lifetime
- 2001-12-18 JP JP2002552164A patent/JP4426179B2/ja not_active Expired - Fee Related
- 2001-12-18 AU AU2002241661A patent/AU2002241661B2/en not_active Ceased
- 2001-12-18 CA CA002430973A patent/CA2430973A1/en not_active Abandoned
- 2001-12-18 AU AU4166102A patent/AU4166102A/xx active Pending
- 2001-12-18 WO PCT/US2001/049256 patent/WO2002050287A2/en active IP Right Grant
- 2001-12-18 AT AT01988344T patent/ATE384800T1/de not_active IP Right Cessation
-
2009
- 2009-08-07 JP JP2009184874A patent/JP2009297031A/ja not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
AU4166102A (en) | 2002-07-01 |
AU2002241661B2 (en) | 2007-05-31 |
JP4426179B2 (ja) | 2010-03-03 |
CA2430973A1 (en) | 2002-06-27 |
EP1366175B1 (de) | 2008-01-23 |
EP1366175A2 (de) | 2003-12-03 |
JP2009297031A (ja) | 2009-12-24 |
JP2004537970A (ja) | 2004-12-24 |
WO2002050287A3 (en) | 2003-09-18 |
DE60132632D1 (de) | 2008-03-13 |
DE60132632T2 (de) | 2009-01-22 |
WO2002050287A2 (en) | 2002-06-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60132632D1 (de) | Multifunktionelle protease-inhibitoren und deren verwendung zur behandlung von krankheiten | |
Amour et al. | The enzymatic activity of ADAM8 and ADAM9 is not regulated by TIMPs | |
NO923469L (no) | Chymotrypsin-lignende proteaser og deres inhibitorer | |
HUP9902698A2 (hu) | Humán bikunin | |
DE60128916D1 (de) | Neues, physiologisch aktives peptid und dessen verwendung | |
ATE266723T1 (de) | Lösung die chaotropische mittel enthält und verwendung dieser lösung in verfahren zur isolierung von dna, rna und proteinen | |
DE69132352T2 (de) | Protein-antagonisten der blut-koagulation und ihre verwendung | |
ATE479095T1 (de) | Prozess und reagenzien für extraktion von rns von fraktionierten blutleukozyten | |
ATE362928T1 (de) | 2-(1h-indazol-6-ylamino)- benzamid-verbindungen als protein kinase inhibitoren und deren verwendung zur behandlung von ophthalmischen krankheiten | |
CY1107342T1 (el) | Χρηση παραγωγων νιτριλιου ως φαρμακο | |
DE60218179D1 (de) | Peptide zur behandlung von tumoren und anderen bedingungen die die entfernung oder zerstörung von zelle erfordern | |
ATE108205T1 (de) | Rekombinantverfahren zur herstellung von serinproteaseinhibitoren, sowie dns-sequenzen dazu. | |
ATE209684T1 (de) | Dna-sequenzen für matrix-metallproteasen, ihre herstellung und verwendung | |
WO1996035788A3 (en) | Kunitz type protease inhibitors | |
RS92704A (en) | Immunoglobulin-domain containing cell surface recognition molecules | |
WO2002022662A3 (en) | Insect inhibitory bacillus thuringiensis proteins, fusions, and methods of use therefor | |
WO2002010357A3 (en) | Gsk3 polypeptides | |
DE69510356D1 (de) | Anti-sickling beta-globin,zusammensetzung und verfahren zur behandlung von sichelzellanämie | |
ATE361914T1 (de) | Cathepsincysteinproteaseinhibitoren und deren verwendung zur behandlung von entzündungen und immunerkrankungen | |
ATE251904T1 (de) | Verwendung von bronopol zur behandlung von krankheiten beim fisch | |
ATE452984T1 (de) | Verfahren und zusammensetzungen zur extraktion von proteinen aus zellen | |
DE60123109D1 (de) | Mit schizophrenie in zusammenhang stehendes gen, das für ein potential-abhängiges ionkanal kodiert | |
ATE431399T1 (de) | Verwendung von cytokinen, zellen und mitogene zur hemmung der graft-versus-host krankheit | |
de Souza et al. | Characterization of a hemorrhage-inducing component present in Bitis arietans venom | |
WO2003036264A3 (en) | Treating diseases mediated by metalloprotease-shed proteins |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |